660 related articles for article (PubMed ID: 25702227)
1. Neuroprotection for traumatic brain injury.
Loane DJ; Stoica BA; Faden AI
Handb Clin Neurol; 2015; 127():343-66. PubMed ID: 25702227
[TBL] [Abstract][Full Text] [Related]
2. Neuroinflammation after traumatic brain injury: opportunities for therapeutic intervention.
Kumar A; Loane DJ
Brain Behav Immun; 2012 Nov; 26(8):1191-201. PubMed ID: 22728326
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective strategies for traumatic brain injury: improving clinical translation.
Kabadi SV; Faden AI
Int J Mol Sci; 2014 Jan; 15(1):1216-36. PubMed ID: 24445258
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies.
Loane DJ; Faden AI
Trends Pharmacol Sci; 2010 Dec; 31(12):596-604. PubMed ID: 21035878
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotection Trials in Traumatic Brain Injury.
Chakraborty S; Skolnick B; Narayan RK
Curr Neurol Neurosci Rep; 2016 Apr; 16(4):29. PubMed ID: 26883431
[TBL] [Abstract][Full Text] [Related]
6. Investigational agents for treatment of traumatic brain injury.
Xiong Y; Zhang Y; Mahmood A; Chopp M
Expert Opin Investig Drugs; 2015 Jun; 24(6):743-60. PubMed ID: 25727893
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in the development of multifactorial therapies for the treatment of traumatic brain injury.
Vink R; Van Den Heuvel C
Expert Opin Investig Drugs; 2004 Oct; 13(10):1263-74. PubMed ID: 15461556
[TBL] [Abstract][Full Text] [Related]
8. Targets of Neuroprotection and Review of Pharmacological Interventions in Traumatic Brain Injury.
Hiskens MI
J Pharmacol Exp Ther; 2022 Aug; 382(2):149-166. PubMed ID: 35644464
[TBL] [Abstract][Full Text] [Related]
9. Neuropharmacology in traumatic brain injury: from preclinical to clinical neuroprotection?
Lerouet D; Marchand-Leroux C; Besson VC
Fundam Clin Pharmacol; 2021 Jun; 35(3):524-538. PubMed ID: 33527472
[TBL] [Abstract][Full Text] [Related]
10. Progesterone neuroprotection: The background of clinical trial failure.
Schumacher M; Denier C; Oudinet JP; Adams D; Guennoun R
J Steroid Biochem Mol Biol; 2016 Jun; 160():53-66. PubMed ID: 26598278
[TBL] [Abstract][Full Text] [Related]
11. Therapies negating neuroinflammation after brain trauma.
Hellewell S; Semple BD; Morganti-Kossmann MC
Brain Res; 2016 Jun; 1640(Pt A):36-56. PubMed ID: 26740405
[TBL] [Abstract][Full Text] [Related]
12. Cell death in the injured brain: roles of metallothioneins.
Pedersen MØ; Larsen A; Stoltenberg M; Penkowa M
Prog Histochem Cytochem; 2009; 44(1):1-27. PubMed ID: 19348909
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotection in traumatic brain injury.
Jain KK
Drug Discov Today; 2008 Dec; 13(23-24):1082-9. PubMed ID: 18848641
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotection in traumatic brain injury: a complex struggle against the biology of nature.
Schouten JW
Curr Opin Crit Care; 2007 Apr; 13(2):134-42. PubMed ID: 17327733
[TBL] [Abstract][Full Text] [Related]
15. Neuroinflammation: beneficial and detrimental effects after traumatic brain injury.
Finnie JW
Inflammopharmacology; 2013 Aug; 21(4):309-20. PubMed ID: 23296919
[TBL] [Abstract][Full Text] [Related]
16. Inflammation and neuroprotection in traumatic brain injury.
Corps KN; Roth TL; McGavern DB
JAMA Neurol; 2015 Mar; 72(3):355-62. PubMed ID: 25599342
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in neuroprotection for treating traumatic brain injury.
Cernak I
Expert Opin Investig Drugs; 2006 Nov; 15(11):1371-81. PubMed ID: 17040197
[TBL] [Abstract][Full Text] [Related]
18. Progesterone in the clinical treatment of acute traumatic brain injury.
Stein DG; Wright DW
Expert Opin Investig Drugs; 2010 Jul; 19(7):847-57. PubMed ID: 20486864
[TBL] [Abstract][Full Text] [Related]
19. Animal modelling of traumatic brain injury in preclinical drug development: where do we go from here?
Marklund N; Hillered L
Br J Pharmacol; 2011 Oct; 164(4):1207-29. PubMed ID: 21175576
[TBL] [Abstract][Full Text] [Related]
20. Exploring new routes for neuroprotective drug development in traumatic brain injury.
Janowitz T; Menon DK
Sci Transl Med; 2010 Apr; 2(27):27rv1. PubMed ID: 20393189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
